FDA ACTIONS

FDA panel votes against wider use of denosumab for prostate-cancer patients

An FDA advisory panel recommended against using denosumab (Xgeva, Amgen) to delay or prevent the spread of castration-resistant prostate cancer at high risk for bone metastases. » More

MEDICATION SAFETY

Study: Commercial e-prescribing can cut hospital med errors

Commercial electronic prescribing systems can significantly reduce medication errors in the hospital setting, according to a study published in PLoS Medicine in January. » More

CONTINUING EDUCATION

Cardiometabolic disease: The pharmacist’s tools for managing dyslipidemia and hypertension

Also known as syndrome X or metabolic syndrome, this condition can lead to diabetes, hypertension, and cardiovascular disease. For patients, pharmacists are an ideal source of information and support. Earn up to 2 CPE credits. » Click here to login and take the exams.

HEALTH SYSTEMS

Report: Drug costs to rise 3% to 5% this year

U.S. drug expenditures remained relatively flat in 2011, but a new report projects that drug costs will rise between 3% and 5% across all healthcare settings this year. » More

ASHP guide: Drug treatments for emergency cardiovascular care

The American Society of Health-System Pharmacists published a new guide about cardiovascular care meant to help pharmacists and other healthcare providers save lives in emergency settings. » More

Hospitals, healthcare facilities urged to require staffs to get flu shots

Hospitals and healthcare facilities should require all employees to get an annual flu shot, a group representing many of the nation’s largest employers emphasized again at a press conference last week in Washington, D.C. » More

Confirm your
e-newsletter subscription click here.

To ensure future delivery of email newsletters from Drug Topics please take a moment to confirm your subscription by clicking here.
Thank you,
Drug Topics Staff

Voices

Digital Edition